- Home
- NMRA vs KOPN Comparison
NMRA vs KOPN Comparison
Compare NMRA & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- KOPN
- Stock Information
- Founded
- NMRA 2019
- KOPN 1984
- Country
- NMRA United States
- KOPN United States
- Employees
- NMRA N/A
- KOPN N/A
- Industry
- NMRA
- KOPN Semiconductors
- Sector
- NMRA
- KOPN Technology
- Exchange
- NMRA Nasdaq
- KOPN Nasdaq
- Market Cap
- NMRA 121.0M
- KOPN 138.4M
- IPO Year
- NMRA 2023
- KOPN 1992
- Fundamental
- Price
- NMRA $0.77
- KOPN $1.63
- Analyst Decision
- NMRA Buy
- KOPN Strong Buy
- Analyst Count
- NMRA 8
- KOPN 3
- Target Price
- NMRA $9.29
- KOPN $2.58
- AVG Volume (30 Days)
- NMRA 847.9K
- KOPN 2.1M
- Earning Date
- NMRA 08-05-2025
- KOPN 08-07-2025
- Dividend Yield
- NMRA N/A
- KOPN N/A
- EPS Growth
- NMRA N/A
- KOPN N/A
- EPS
- NMRA N/A
- KOPN N/A
- Revenue
- NMRA N/A
- KOPN $50,841,018.00
- Revenue This Year
- NMRA N/A
- KOPN $8.02
- Revenue Next Year
- NMRA N/A
- KOPN $20.99
- P/E Ratio
- NMRA N/A
- KOPN N/A
- Revenue Growth
- NMRA N/A
- KOPN 28.16
- 52 Week Low
- NMRA $0.61
- KOPN $0.56
- 52 Week High
- NMRA $17.19
- KOPN $2.17
- Technical
- Relative Strength Index (RSI)
- NMRA 45.74
- KOPN 61.99
- Support Level
- NMRA $0.81
- KOPN $1.58
- Resistance Level
- NMRA $1.34
- KOPN $1.69
- Average True Range (ATR)
- NMRA 0.10
- KOPN 0.09
- MACD
- NMRA -0.01
- KOPN 0.01
- Stochastic Oscillator
- NMRA 12.55
- KOPN 80.00
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.